A new psychedelic era dawns in America

Psychedelic policy and commercialization are converging in the US, signaling a broader shift toward a new era. The piece frames this change as more than individual experimentation, pointing to the growing institutional and market momentum around psychedelics. It emphasizes the societal consequences of expanding availability and attention, including how regulation and investment shape what reaches clinicians and consumers. Overall, it connects the rise of psychedelics in public debate with evolving industry structures and policy decisions that will influence mainstream adoption.